Cytotoxic Potential of Betulinic Acid Fatty Esters and Their Liposomal Formulations: Targeting Breast, Colon, and Lung Cancer Cell Lines
Molecules · 19.07.2024 · 29 (14) · 3399
DOI: 10.3390/molecules29143399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 19.07.2024. Verfasst von Andreea Milan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timișoara, Romania. Hauptthemen laut MEDLINE: Betulinic Acid, Liposomes, Pentacyclic Triterpenes, Esters. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Victor Babes Timisoara, Victor Babes University of Medicine and Pharmacy Timisoara.
Abstract (Originalsprache)
Betulinic acid is a lupane-type pentacyclic triterpene mostly found in birch bark and thoroughly explored for its wide range of pharmacological activities. Despite its impressive biological potential, its low bioavailability has challenged many researchers to develop different formulations for achieving better in vitro and in vivo effects. We previously reported the synthesis of fatty acid esters of betulinic acid using butyric, stearic, and palmitic acids (But-BA, St-BA, and Pal-BA) and included them in surfaced-modified liposomes (But-BA-Lip, St-BA-Lip, Pal-BA-Lip). In the current study, we evaluated the cytotoxic effects of both fatty acid esters and their respective liposomal formulations against MCF-7, HT-29, and NCI-H460 cell line. The cytotoxic assessment of BA derivatives revealed that both the fatty esters and their liposomal formulations acted as cytotoxic agents in a dose- and time-dependent manner. But-BA-Lip exerted stronger cytotoxic effects than the parent compound, BA and its liposomal formulation, and even stronger effects than 5-FU against HT-29 cells (IC50 of 30.57 μM) and NCI-H460 cells (IC50 of 30.74 μM). BA’s fatty esters and their respective liposomal formulations facilitated apoptosis in cancer cells by inducing nuclear morphological changes and increasing caspase-3/-7 activity. The HET-CAM assay proved that none of the tested compounds induced any irritative effect, suggesting that they can be used safely for local applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timișoara, Romania.
- Research Centre for Pharmaco-Toxicological Evaluation, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timișoara, Romania.
- Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timișoara, Romania.
- Institute of Chemistry Coriolan Drăgulescu, 24 Mihai Viteazu Ave, 300223 Timișoara, Romania.
ORCID-Profile: Andreea Milan, Armand Gogulescu, Ștefana Avram
Förderung
- University of Medicine and Pharmacy Victor Babes Timisoara
- Victor Babes University of Medicine and Pharmacy Timisoara
Zitieren
APA
Milan, A., Mioc, M., Mioc, A., Gogulescu, A., Mardale, G., Avram, Ș., Maksimović, T., Mara, B., & Șoica, C. (2024). Cytotoxic Potential of Betulinic Acid Fatty Esters and Their Liposomal Formulations: Targeting Breast, Colon, and Lung Cancer Cell Lines. Molecules, 29(14), 3399. https://doi.org/10.3390/molecules29143399
Vancouver
Milan A, Mioc M, Mioc A, Gogulescu A, Mardale G, Avram Ș, et al. Cytotoxic Potential of Betulinic Acid Fatty Esters and Their Liposomal Formulations: Targeting Breast, Colon, and Lung Cancer Cell Lines. Molecules. 2024;29(14):3399. doi:10.3390/molecules29143399
BibTeX
@article{Milan2024,
author = {Milan, Andreea and Mioc, Marius and Mioc, Alexandra and Gogulescu, Armand and Mardale, Gabriel and Avram, Ștefana and Maksimović, Tamara and Mara, Bogdan and Șoica, Codruța},
title = {Cytotoxic Potential of Betulinic Acid Fatty Esters and Their Liposomal Formulations: Targeting Breast, Colon, and Lung Cancer Cell Lines},
journal = {Molecules},
year = {2024},
volume = {29},
number = {14},
pages = {3399},
doi = {10.3390/molecules29143399}
}
EUVIMED